Research News and Research

RSS
Once-a-week injectable insulin therapy proves to be safe, effective in people with Type 2 diabetes

Once-a-week injectable insulin therapy proves to be safe, effective in people with Type 2 diabetes

Researchers manufacture the SARS-CoV-2 RBD in pichia

Researchers manufacture the SARS-CoV-2 RBD in pichia

Researchers decipher the molecular underpinning of exceptional responses in glioblastoma patients

Researchers decipher the molecular underpinning of exceptional responses in glioblastoma patients

Study illustrates the profound impact of postponing cardiovascular surgeries due to COVID-19

Study illustrates the profound impact of postponing cardiovascular surgeries due to COVID-19

One dose of mRNA vaccine may be sufficient for individuals previously infected with SARS-CoV-2

One dose of mRNA vaccine may be sufficient for individuals previously infected with SARS-CoV-2

New microfluidic system effectively isolates cancer spreading cells

New microfluidic system effectively isolates cancer spreading cells

Research team identifies new factor in the development of psoriasis

Research team identifies new factor in the development of psoriasis

Study sheds new light on the ability of pancreatic cancer cells to metastasize

Study sheds new light on the ability of pancreatic cancer cells to metastasize

Protein-coding gene may worsen tau protein tangles associated with Alzheimer's

Protein-coding gene may worsen tau protein tangles associated with Alzheimer's

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

Gene therapy for common forms of congenital blindness shows promise to improve vision

Gene therapy for common forms of congenital blindness shows promise to improve vision

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Researchers develop computational model to predict changes in SARS-CoV-2’s viral fitness

Researchers develop computational model to predict changes in SARS-CoV-2’s viral fitness

Phico Therapeutics awarded up to $18.2 million USD (c.£13.2 million GBP) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials

Phico Therapeutics awarded up to $18.2 million USD (c.£13.2 million GBP) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials

Plant-derived compound isorhamnetin may have antiviral potential against SARS-CoV-2

Plant-derived compound isorhamnetin may have antiviral potential against SARS-CoV-2

Defects in specific goblet cells may be a factor contributing to ulcerative colitis

Defects in specific goblet cells may be a factor contributing to ulcerative colitis

Gender-affirming hormone therapy linked to blood pressure changes in transgender people

Gender-affirming hormone therapy linked to blood pressure changes in transgender people

Snag a vaccine appointment, then face the next hurdle: How to get there?

Snag a vaccine appointment, then face the next hurdle: How to get there?

Study assess prevalence of SARS-CoV-2 in England after third national lockdown

Study assess prevalence of SARS-CoV-2 in England after third national lockdown

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.